1,3,5-Trisubstituted-1,2,4-triazole compounds
    11.
    发明授权
    1,3,5-Trisubstituted-1,2,4-triazole compounds 失效
    1,3,5-三取代-1,2,4-三唑化合物

    公开(公告)号:US4048183A

    公开(公告)日:1977-09-13

    申请号:US672899

    申请日:1976-04-02

    IPC分类号: C07D401/14 C07D413/06

    CPC分类号: C07D401/14 C07D413/06

    摘要: Compounds useful in the treatment of asthma, the symptoms of allergy and in some instances in gout and hyperuricemia are described. The novel compounds are 1-substituted-1,2,4-triazoles being additionally substituted at the 3- and 5-positions with a pyridyl radical. Methods of preparing these tri-substituted triazoles are described.

    摘要翻译: 描述了可用于治疗哮喘,过敏症状以及在一些情况下在痛风和高尿酸血症中的化合物。 新化合物是在3-和5-位用吡啶基进一步取代的1-取代-1,2,4-三唑。 描述了制备这些三取代三唑的方法。

    3-Diazine substituted benzothiadiazines
    12.
    发明授权
    3-Diazine substituted benzothiadiazines 失效
    3-二嗪取代苯并噻二嗪

    公开(公告)号:US3988324A

    公开(公告)日:1976-10-26

    申请号:US609111

    申请日:1975-08-29

    CPC分类号: C07D417/04

    摘要: 3-Diazine(or substituted diazine)-1,2,4-benzothiadiazine-1,1-dioxide products or 3,4-dihydro derivatives thereof are described. Products are prepared by conventional methods employing the appropriate sulfamoylaniline and diazine carboxylic acid halide or diazine carboxaldehyde. Products are xanthine oxidase inhibitors.

    摘要翻译: 描述了3-二嗪(或取代的二嗪)-1,2,4-苯并噻二嗪-1,1-二氧化物产物或其3,4-二氢衍生物。 产物通过常规方法制备,使用合适的氨磺酰苯胺和二嗪羧酸卤化物或二嗪甲醛。 产品是黄嘌呤氧化酶抑制剂。

    Inhibiting xanthine oxidase with 3-haloalkyl substituted
benzothiadiazine-1,1-dioxides
    14.
    发明授权
    Inhibiting xanthine oxidase with 3-haloalkyl substituted benzothiadiazine-1,1-dioxides 失效
    用3-卤代烷基取代的苯并噻二嗪-1,1-二氧化物抑制黄嘌呤氧化酶

    公开(公告)号:US3969518A

    公开(公告)日:1976-07-13

    申请号:US256224

    申请日:1972-05-24

    IPC分类号: C07D285/30 A61K19/02

    CPC分类号: C07D285/30

    摘要: Method for decreasing the concentration of uric acid in the blood and urine of a mammal by the administration of a 3-haloalkyl-1,2,4-benzothiadiazine-1,1-dioxide product or 3,4-dihydro derivative thereof. The products employed in this method of treatment are prepared by conventional methods employing the appropriate orthanilamide and haloalkanoic acid halide or carboxaldehyde. The products effect the lowering of the uric acid level by virtue of their xanthine oxidase inhibiting properties.

    摘要翻译: 通过给予3-卤代烷基-1,2,4-苯并噻二嗪-1,1-二氧化物产物或其3,4-二氢衍生物来降低哺乳动物血液和尿液中尿酸浓度的方法。 在这种处理方法中使用的产物是通过常规方法制备的,该方法采用合适的对羟基苯甲酰胺和卤代链烷酰卤或甲醛。 该产品由于其黄嘌呤氧化酶抑制性质而影响尿酸水平的降低。

    Anti-hyperuricemia composition
    16.
    发明授权
    Anti-hyperuricemia composition 失效
    抗高尿酸血症组成

    公开(公告)号:US4111944A

    公开(公告)日:1978-09-05

    申请号:US808575

    申请日:1977-06-21

    IPC分类号: C07D401/02 C07D401/14

    CPC分类号: C07D401/14

    摘要: Compositions useful in the treatment of gout and hyperuricemia and containing a substituted 1,2,4-triazole as the active ingredient are provided, the triazoles being substituted at the 5 position with a pyridyl radical and at the 3 position with a phenyl or a pyridyl radical. Methods of preparing these substituted triazoles are described. Certain of the compounds are novel.

    摘要翻译: 提供了可用于治疗痛风和高尿酸血症并含有取代的1,2,4-三唑作为活性成分的组合物,三唑在5位被吡啶基取代,在3位被苯基或吡啶基 激进。 描述制备这些取代的三唑的方法。 某些化合物是新颖的。

    1,3,5-Trisubstituted-1,2,4-triazole compounds used as bronchodilators
    17.
    发明授权
    1,3,5-Trisubstituted-1,2,4-triazole compounds used as bronchodilators 失效
    用作支气管扩张剂的1,3,5-三取代-1,2,4-三唑化合物

    公开(公告)号:US3984558A

    公开(公告)日:1976-10-05

    申请号:US527994

    申请日:1974-11-29

    IPC分类号: A61K31/44 C07D401/14

    摘要: Compounds useful in the treatment of asthma, the symptoms of allergy and in some instances in gout and hyperuricemia are described. The novel compounds are 1-substituted-1,2,4-triazoles being additionally substituted at the 3- and 5-positions with a pyridyl radical. Methods of preparing these tri-substituted triazoles are described.

    摘要翻译: 描述了可用于治疗哮喘,过敏症状以及在一些情况下在痛风和高尿酸血症中的化合物。 新化合物是在3-和5-位用吡啶基进一步取代的1-取代-1,2,4-三唑。 描述了制备这些三取代三唑的方法。

    7-Mercapto(or thio)-benzothiadiazine products
    18.
    发明授权
    7-Mercapto(or thio)-benzothiadiazine products 失效
    7-巯基(或硫代) - 苯并噻二嗪产物

    公开(公告)号:US3960854A

    公开(公告)日:1976-06-01

    申请号:US534404

    申请日:1974-12-19

    CPC分类号: C07D417/04 C07D285/24

    摘要: 7-Mercapto(or alkyl- or aralkylthio)-1,2,4-benzothiadiazine-1,1-dioxide compounds are described. Products are prepared by reducing a 7-chlorosulfonyl substituent to the 7-mercapto and then, if desired, alkylating or aralkylating to provide 7-thio substituent. Alternatively, a 4-RS-orthanilamide can be cyclized by known procedures to provide a 3-unsubstituted or 3-substituted analog. Products are xanthine oxidase inhibitors.

    摘要翻译: 描述了7-巯基(或烷基 - 或芳烷硫基)-1,2,4-苯并噻二嗪-1,1-二氧化物。 通过将7-氯磺酰基取代基还原为7-巯基,然后如果需要,通过烷基化或芳烷基化以提供7-硫取代基来制备产物。 或者,可以通过已知的方法使4-RS-邻苯二甲酰胺环化以提供3-未取代的或3-取代的类似物。 产品是黄嘌呤氧化酶抑制剂。